JP2006519605A5 - - Google Patents

Download PDF

Info

Publication number
JP2006519605A5
JP2006519605A5 JP2006506942A JP2006506942A JP2006519605A5 JP 2006519605 A5 JP2006519605 A5 JP 2006519605A5 JP 2006506942 A JP2006506942 A JP 2006506942A JP 2006506942 A JP2006506942 A JP 2006506942A JP 2006519605 A5 JP2006519605 A5 JP 2006519605A5
Authority
JP
Japan
Prior art keywords
seq
composition
nthi
polypeptide
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006506942A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006519605A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/007001 external-priority patent/WO2004078949A2/en
Publication of JP2006519605A publication Critical patent/JP2006519605A/ja
Publication of JP2006519605A5 publication Critical patent/JP2006519605A5/ja
Withdrawn legal-status Critical Current

Links

JP2006506942A 2003-03-06 2004-03-05 類型不能haemophilusinfluenzaeの中耳炎単離株の遺伝子 Withdrawn JP2006519605A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45313403P 2003-03-06 2003-03-06
PCT/US2004/007001 WO2004078949A2 (en) 2003-03-06 2004-03-05 Genes of an otitis media isolate of nontypeable haemophilus influenzae

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010139968A Division JP2010279359A (ja) 2003-03-06 2010-06-18 類型不能haemophilusinfluenzaeの中耳炎単離株の遺伝子

Publications (2)

Publication Number Publication Date
JP2006519605A JP2006519605A (ja) 2006-08-31
JP2006519605A5 true JP2006519605A5 (enExample) 2007-05-24

Family

ID=32962758

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2006506942A Withdrawn JP2006519605A (ja) 2003-03-06 2004-03-05 類型不能haemophilusinfluenzaeの中耳炎単離株の遺伝子
JP2010139968A Pending JP2010279359A (ja) 2003-03-06 2010-06-18 類型不能haemophilusinfluenzaeの中耳炎単離株の遺伝子
JP2014017053A Pending JP2014132901A (ja) 2003-03-06 2014-01-31 類型不能haemophilusinfluenzaeの中耳炎単離株の遺伝子

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2010139968A Pending JP2010279359A (ja) 2003-03-06 2010-06-18 類型不能haemophilusinfluenzaeの中耳炎単離株の遺伝子
JP2014017053A Pending JP2014132901A (ja) 2003-03-06 2014-01-31 類型不能haemophilusinfluenzaeの中耳炎単離株の遺伝子

Country Status (5)

Country Link
US (7) US7241867B2 (enExample)
EP (2) EP2330117A1 (enExample)
JP (3) JP2006519605A (enExample)
CA (2) CA2796381A1 (enExample)
WO (1) WO2004078949A2 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2520386A1 (en) * 2003-03-27 2004-10-14 Children's Hospital, Inc. Nontypeable haemophilus influenzae virulence factors
GB0410866D0 (en) 2004-05-14 2004-06-16 Chiron Srl Haemophilius influenzae
BRPI0609460A2 (pt) * 2005-03-30 2010-04-13 Novartis Vaccines & Diagnostics Inc haemophilus influenzae tipo b
CA2871088A1 (en) * 2005-06-16 2006-12-28 Lauren O. Bakaletz Genes of an otitis media isolate of nontypeable haemophilus influenzae
US7384770B1 (en) * 2007-01-09 2008-06-10 Gas Technology Institute Rapid quantification of acetic acid-producing bacteria using real-time PCR
WO2010092176A2 (en) * 2009-02-13 2010-08-19 Intercell Ag Nontypable haemophilus influenzae antigens
WO2010123885A2 (en) * 2009-04-20 2010-10-28 Tufts Medical Center, Inc. Iga1 protease polypeptide agents and uses thereof
CN103180459B (zh) * 2010-07-09 2016-10-19 赛尔冉迪思股份有限公司 3-d目的基因组区域的测序策略
AU2011299025B2 (en) 2010-09-09 2015-07-09 Nationwide Children's Hospital, Inc. Compositions and methods for the removal of biofilms
JP5541137B2 (ja) 2010-12-15 2014-07-09 ソニー株式会社 撮像装置、電子機器、太陽電池、および、撮像装置の製造方法
US11274144B2 (en) * 2013-06-13 2022-03-15 Research Institute At Nationwide Children's Hospital Compositions and methods for the removal of biofilms
US9745366B2 (en) 2013-09-23 2017-08-29 University Of Southern California Compositions and methods for the prevention of microbial infections
US11248040B2 (en) 2013-09-26 2022-02-15 Trellis Bioscience, Llc Binding moieties for biofilm remediation
US10233234B2 (en) 2014-01-13 2019-03-19 Trellis Bioscience, Llc Binding moieties for biofilm remediation
US9580758B2 (en) 2013-11-12 2017-02-28 Luc Montagnier System and method for the detection and treatment of infection by a microbial agent associated with HIV infection
US10624934B2 (en) 2014-03-06 2020-04-21 Research Institute At Nationwide Children's Hospital Prebiotic formulations
CA2941694A1 (en) 2014-03-06 2015-09-11 Research Institute At Nationwide Children's Hospital Probiotic formulations and methods for use
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US20180207067A1 (en) 2015-07-14 2018-07-26 Research Institute at Nationwide Children's Hospit al Novel formulation for the elimination of cariogenic and opportunistic pathogens within the oral cavity
AU2016303688B2 (en) 2015-07-31 2023-06-15 Research Institute At Nationwide Children's Hospital Peptides and antibodies for the removal of biofilms
WO2017066719A2 (en) 2015-10-14 2017-04-20 Research Institute At Nationwide Children's Hospital Hu specific interfering agents
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
AU2018206560B9 (en) 2017-01-04 2025-04-03 Research Institute At Nationwide Children's Hospital Antibody fragments for the treatment of biofilm-related disorders
JP7514621B2 (ja) 2017-01-04 2024-07-11 リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル Dnabiiワクチンおよび強化された活性を有する抗体
US11746136B2 (en) 2017-03-15 2023-09-05 Research Institute At Nationwide Children's Hospital Composition and methods for disruption of bacterial biofilms without accompanying inflammation
KR20210070331A (ko) 2018-10-05 2021-06-14 더 리서치 인스티튜트 앳 네이션와이드 칠드런스 하스피탈 생물막 제거를 위한 hmgb1 단백질 유도체
EP3870154A4 (en) 2018-10-22 2022-07-27 Research Institute at Nationwide Children's Hospital COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF ANTIBIOTIC-INDUCED PATHOLOGIES USING PROBIOTICS IN BIOFILM STATE
US20220143168A1 (en) * 2019-02-27 2022-05-12 Evaxion Biotech A/S Vaccines targeting H. influenzae
WO2020247536A1 (en) 2019-06-03 2020-12-10 Research Institute At Nationwide Children's Hospital Prebiotic formulations for prevention of sepsis and necroenterocolitis induced neurodevelopmental deficiencies

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US453134A (en) 1891-05-26 Fire-escape
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
AU4490797A (en) * 1996-09-23 1998-04-14 Children's Hospital Of Philadelphia, The Compositions and methods for treatment of infection caused by (haemophilus influenzae) and (streptococcus pneumoniae)
EP1029052B1 (en) * 1997-11-06 2010-08-04 Novartis Vaccines and Diagnostics S.r.l. Neisserial antigens
US5997280A (en) 1997-11-07 1999-12-07 Maxon Corporation Intelligent burner control system
EP1144643A1 (en) 1999-01-15 2001-10-17 SMITHKLINE BEECHAM BIOLOGICALS s.a. Neisseria meningitidis antigen
AU2109700A (en) * 1999-01-22 2000-08-07 Smithkline Beecham Biologicals (Sa) Novel compounds
GB0026002D0 (en) * 2000-10-24 2000-12-13 Smithkline Beecham Biolog Novel compounds

Similar Documents

Publication Publication Date Title
JP2006519605A5 (enExample)
JP2008546390A5 (enExample)
Leavis et al. A novel putative enterococcal pathogenicity island linked to the esp virulence gene of Enterococcus faecium and associated with epidemicity
JP2008520242A5 (enExample)
EP2694685B1 (en) Detection of nucleic acids using unmodified gold nanoparticles
JP2002542798A5 (enExample)
CA2582137A1 (en) Probe arrays for detecting multiple strains of different species
JP2010536372A5 (enExample)
Stelzer-Braid et al. Detection of viral and bacterial respiratory pathogens in patients with cystic fibrosis
ES2303395B1 (es) Sondas y metodos para la deteccion e identificacion simultanea de multiples virus causantes de infecciones respiratorias en humanos.
Mohan et al. Hemagglutinin gene based biosensor for early detection of swine flu (H1N1) infection in human
JP2013178260A5 (enExample)
JP2002531522A5 (enExample)
JP2018518180A (ja) 感染性疾患の診断および処置
Kamio et al. Porphyromonas gingivalis enhances pneumococcal adhesion to human alveolar epithelial cells by increasing expression of host platelet‐activating factor receptor
WO2015006755A2 (en) Recombinase polymerase amplification (rpa) method for leishmania spp. and trypanosoma cruzi
WO2005001097A1 (ja) Sarsコロナウイルスの検出法
CN111212911B (zh) 与tb7.7特异性结合的dna适体及其用途
JP5204466B2 (ja) マイコプラズマ・ニューモニエ(Mycoplasmapneumoniae)の検出方法
Posuwan et al. Prevalence of respiratory viruses isolated from dogs in Thailand during 2008-2009
Orlova et al. Constitutive differences in gene expression profiles parallel genetic patterns of susceptibility to tuberculosis in mice
JP2006520587A5 (enExample)
JP2009189283A (ja) 結核菌および非結核性抗酸菌検出試薬
FR2778415A1 (fr) Fragment d'adn gc3 specifique de neisseria gonorrhoeae
JP2009544326A (ja) インターナリンb又はインターナリンaと結合可能な核酸リガンド